The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InPhibro Animal Health Corporation (PAHC) reported robust financial results for the third quarter ended March 31, 2026, achieving net sales of $383.5 million. This performance represents a 10% increase compared to the previous year, highlighting the company's operational strength. Net income also saw a significant rise to $24.0 million, marking a 15% growth over the same quarter in 2025. Alongside these results, the company provided updated financial guidance for the full fiscal year ending June 30, 2026. This report serves to inform investors of Phibro's sustained growth trajectory within the animal health sector. The positive double-digit growth in both sales and income underscores the company's ability to enhance profitability amid current market conditions.